Riley AI | $3,000,000 | (Jan 24, 2025)
StormHarvester | $10,379,211 | (Jan 24, 2025)
Mergus Ventures | $6,300,000 | (Jan 24, 2025)
Certified by Founder
Lodge
Bryleos
start up
United States
- Johnson City, Tennessee
- 14/06/2023
- Seed
- $5,000,000
Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders.
In 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.
Bryleos: More Life While Living
- Industry Biotechnology Research
- Website https://bryleos.com/
- LinkedIn https://www.linkedin.com/company/bryleos/
Baya Systems | $36,000,000 | (Jan 24, 2025)
Clutch(US) | $65,000,000 | (Jan 24, 2025)
VuNet Systems | $6,940,480 | (Jan 24, 2025)
Method | $41,500,000 | (Jan 24, 2025)
Palona AI | $10,000,000 | (Jan 24, 2025)
Almanax | $1,000,000 | (Jan 24, 2025)
ZuriQ | $4,200,000 | (Jan 24, 2025)
CapeZero | $2,600,000 | (Jan 24, 2025)
Lanai | $10,000,000 | (Jan 24, 2025)